Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Covington

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bulletin of the Parenteral Drug Association|March 1, 1971
The future impact of clinical pharmacy on parenteral drugs and the industryH A Whitney, T R Covington
Journal of the American Dietetic Association|March 1, 1977
Total parenteral nutrition. A brief reviewP Herlihy, W F Stanaszek, T R Covington
Hospital Practice (Office Ed.)|November 1, 1984
Pharmacologic therapy of seizures in the elderlyE L Mancall, T R Covington, R J Alonso
American Pharmacy|September 1, 1991
Drug product selection--Part 3: The Orange BookR E Parker, D R Martinez, T R Covington
Hospital Practice (Office Ed.)|October 1, 1984
Therapy of neurologic disorders in the elderlyE L Mancall, T R Covington, R J Alonso
American Pharmacy|July 1, 1991
Drug product selection--Part 1: History and legal overviewR E Parker, D R Martinez, T R Covington
Toxicology|July 17, 1996
Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroformB C Allen, T R Covington, H J Clewell
Pharmacotherapy|March 1, 1993
Developing drug use evaluation criteria for parenteral fluoroquinolonesD R Guay, T R Covington, V L Alexander
American Journal of Hospital Pharmacy|May 1, 1974
Drug defaulting. II. Analysis of noncompliance patternsJ R Boyd, T R Covington, W F Stanaszek, et al.
Environmental Health Perspectives|May 12, 2000
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessmentH J Clewell, P R Gentry, T R Covington, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bulletin of the Parenteral Drug Association|March 1, 1971
The future impact of clinical pharmacy on parenteral drugs and the industryH A Whitney, T R Covington
Journal of the American Dietetic Association|March 1, 1977
Total parenteral nutrition. A brief reviewP Herlihy, W F Stanaszek, T R Covington
Hospital Practice (Office Ed.)|November 1, 1984
Pharmacologic therapy of seizures in the elderlyE L Mancall, T R Covington, R J Alonso
American Pharmacy|September 1, 1991
Drug product selection--Part 3: The Orange BookR E Parker, D R Martinez, T R Covington
Hospital Practice (Office Ed.)|October 1, 1984
Therapy of neurologic disorders in the elderlyE L Mancall, T R Covington, R J Alonso
American Pharmacy|July 1, 1991
Drug product selection--Part 1: History and legal overviewR E Parker, D R Martinez, T R Covington
Toxicology|July 17, 1996
Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroformB C Allen, T R Covington, H J Clewell
Pharmacotherapy|March 1, 1993
Developing drug use evaluation criteria for parenteral fluoroquinolonesD R Guay, T R Covington, V L Alexander
American Journal of Hospital Pharmacy|May 1, 1974
Drug defaulting. II. Analysis of noncompliance patternsJ R Boyd, T R Covington, W F Stanaszek, et al.
Environmental Health Perspectives|May 12, 2000
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessmentH J Clewell, P R Gentry, T R Covington, et al.
Pageof 3